Micro-nanoplastics and cardiovascular diseases: evidence and perspectives.
Francesco Prattichizzo, Antonio Ceriello, Valeria Pellegrini...
https://pubmed.ncbi.nlm.nih.gov/39240674/Actively Recruiting
Led by Azienda Ospedaliera "Sant'Andrea" · Updated on 2026-06-09
120
Participants Needed
6
Research Sites
156 weeks
Total Duration
Researchers are investigating the presence and impact of microplastics and nanoplastics MNPs in adults with chronic coronary syndromes CCS undergoing coronary CT angiography CCTA and invasive coronary angiography. This observational study aims to analyze these particles in coronary blood and explore their relationship with coronary artery disease features, including plaque characteristics and vessel ischemia. Patients are followed up clinically at 1 and 3 years according to standard care. Participants undergo routine coronary CT angiography to assess suspected or known CCS and then invasive coronary angiography when clinically indicated. During invasive procedures, coronary blood samples are collected for central laboratory analysis of MNPs using specialized techniques such as pyrolysis-gas chromatography-mass spectrometry and laser direct infrared spectroscopy. The CCTA images are centrally evaluated to quantify and characterize coronary plaques. Patients are grouped based on the presence or absence of MNPs in coronary blood. Throughout the study, patients receive standard clinical management without changes to their care. Data collected include coronary blood MNP burden, plaque features from CCTA, and clinical outcomes such as major adverse cardiovascular events and mortality over 1- and 3-year follow-ups. The study monitors correlations between MNP levels and various imaging and clinical parameters to better understand their role in CCS progression and outcomes.
CONDITIONS
Microplastics and Nanoplastics in Patients With Chronic Coronary Syndromes
E
Emanuele Barbato, MD, PhD
C
Clinical Research Unit Cardiology Dept. Sant'Andrea University Hospital
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Azienda Ospedaliera "Sant'Andrea"
Lead Sponsor
University of Campania Luigi Vanvitelli
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 7 days
Participants undergo coronary CT angiography to assess coronary plaques and chronic coronary syndromes. Images are centrally analyzed to evaluate plaque features.
1 visit for coronary CT angiography
Duration - Up to 7 days
Participants have invasive coronary angiography as clinically indicated. During the procedure, coronary blood samples are collected to measure microplastics and nanoplastics.
1 invasive angiography visit
Duration - 3 years
Participants are followed clinically at 1 and 3 years to assess health outcomes and monitor cardiovascular events.
Follow-up visits at 1 year and 3 years
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Francesco Prattichizzo, Antonio Ceriello, Valeria Pellegrini...
https://pubmed.ncbi.nlm.nih.gov/39240674/Sheng Liu, Chenyang Wang, Yunxiao Yang...
https://pubmed.ncbi.nlm.nih.gov/38428296/Tingting Wang, Zhiheng Yi, Xiaoqiang Liu...
https://pubmed.ncbi.nlm.nih.gov/38614011/Duk-Hee Lee
https://pubmed.ncbi.nlm.nih.gov/39283932/Raffaele Marfella, Francesco Prattichizzo, Celestino Sardu...
https://pubmed.ncbi.nlm.nih.gov/38446676/Azienda Ospedaliera "Sant'Andrea"
Lead Sponsor
University of Campania Luigi Vanvitelli
Collaborating Sponsor